FDA Inspection 1192191 — Sibel Health Inc.
The FDA completed an inspection of Sibel Health Inc. on Nov 18, 2022 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 18, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Chicago, IL (United States)
Additional Details
Sponsor, Contract Research Organization